|Bid||195.74 x 800|
|Ask||196.19 x 1300|
|Day's range||195.37 - 201.33|
|52-week range||189.40 - 301.34|
|Beta (5Y monthly)||0.45|
|PE ratio (TTM)||37.15|
|Earnings date||03 Aug 2022 - 08 Aug 2022|
|Forward dividend & yield||1.68 (0.85%)|
|Ex-dividend date||11 May 2022|
|1y target est||240.83|
With its stock down 19% over the past month, it is easy to disregard ResMed (NYSE:RMD). But if you pay close attention...
2–3 hours of nightly PAP use shows health benefits at 3 months, 1 year, and 2 yearsHealth benefits significantly increase by use hour/night, up to 7 hours SAN FRANCISCO, May 18, 2022 (GLOBE NEWSWIRE) -- Sleep apnea sufferers can gain health benefits from PAP (positive airway pressure) treatment in as little as two hours per night, according to a study led by ResMed (NYSE: RMD, ASX: RMD) and presented at the American Thoracic Society’s annual International Conference. The retrospective, observati
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...